Unified Patents, LLC (also referred to as Unified Patents) is a private, member-based organization founded in 2012, with its headquarters noted in San Jose, California, and corporate offices in Washington, D.C. and Chevy Chase, Maryland. The company was acquired by WestView Capital in 2019 and is private equity-backed. Unified Patents' employee count has been reported between 36 and 50 as of 2026, though it was 250 in 2019.
Unified Patents provides patent risk mitigation services aimed at improving patent quality and deterring unsubstantiated patent assertions, particularly from Non-Practicing Entities (NPEs). Their services include patent analytics, prior art research, invalidity contests (such as Inter Partes Reviews or IPRs, and ex parte reexaminations), patentability analysis, and amicus briefs within defined technology sectors ("Zones"). They do not purchase or license patents from NPEs, focusing instead on challenging the validity of patents.
Unified Patents' litigation posture is characterized by its role as a patent challenger, predominantly filing petitions to invalidate patents held by NPEs. The company is a prominent petitioner in Patent Trial and Appeal Board (PTAB) cases and has been recognized as a leading third-party filer for IPRs and ex parte reexaminations. Their objective is to protect operating companies from what they characterize as frivolous patent litigation, acting as a plaintiff in these administrative challenges.
A notable tracked case for Unified Patents is Petitioner (associated with Unified Patents) v. Guardant Health Inc. at the Patent Trial and Appeal Board. This aligns with their stated mission to challenge patents in PTAB proceedings. Unified Patents has also successfully challenged patents from entities like Voice Tech Corp. and MemoryWeb, LLC through IPRs, securing affirmations of unpatentability at the Federal Circuit in some instances.